Michalis Georgiou1, Parampal S Grewal2, Akshay Narayan3, Muath Alser3, Naser Ali2, Kaoru Fujinami4, Andrew R Webster1, Michel Michaelides5. 1. Institute of Ophthalmology, University College London, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom. 2. UCL Institute of Ophthalmology, University College London, London, United Kingdom. 3. Institute of Ophthalmology, University College London, London, United Kingdom. 4. Institute of Ophthalmology, University College London, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom; Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. 5. Institute of Ophthalmology, University College London, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom. Electronic address: michel.michaelides@ucl.ac.uk.
Abstract
PURPOSE: To determine the genetic background of sector retinitis pigmentosa (RP) natural history to better inform patient counseling. DESIGN: Retrospective case series. METHODS: Review of clinical notes, retinal imaging including color fundus photography (CFP), fundus autofluorescence (FAF), optical coherence tomography (OCT), electrophysiological assessment (ERG), and molecular genetic testing were performed in patients with sector RP from a single tertiary referral center. Main outcomes measured were demographic data, signs and symptoms, visual acuity, molecular genetics; and ERG, FAF, and OCT findings. RESULTS: Twenty-six molecularly confirmed patients from 23 different families were identified harboring likely disease-causing variants in 9 genes. The modes of inheritance were autosomal recessive (AR, n=6: USH1C, n=2; MYO7A, n=2; CDH3, n=1; EYS, n=1), X-linked (XL, n=4: PRPS1, n=1; RPGR, n=3), and autosomal dominant (AD, n=16: IMPDH1, n=3; RP1, n=3; RHO, n=10), with a mean age of disease onset of 38.5, 30.5, and 39.0 years old, respectively. Five of these genes have not previously been reported to cause sector RP (PRPS1, MYO7A, EYS, IMPDH1, and RP1). Inferior and nasal predilection was common across the different genotypes, and patients tended to maintain good central vision. Progression on serial FAF was observed in RPGR, MYO7A, CDH23, EYS, IMPDH1, RP1, and RHO-associated sector RP. CONCLUSIONS: The genotypic spectrum of the disease is broader than previously reported. The longitudinal data provided will help to make accurate patient prognoses and counseling as well as inform patients' potential participation in the increasing numbers of trials of novel therapeutics and access to future treatments.
PURPOSE: To determine the genetic background of sector retinitis pigmentosa (RP) natural history to better inform patient counseling. DESIGN: Retrospective case series. METHODS: Review of clinical notes, retinal imaging including color fundus photography (CFP), fundus autofluorescence (FAF), optical coherence tomography (OCT), electrophysiological assessment (ERG), and molecular genetic testing were performed in patients with sector RP from a single tertiary referral center. Main outcomes measured were demographic data, signs and symptoms, visual acuity, molecular genetics; and ERG, FAF, and OCT findings. RESULTS: Twenty-six molecularly confirmed patients from 23 different families were identified harboring likely disease-causing variants in 9 genes. The modes of inheritance were autosomal recessive (AR, n=6: USH1C, n=2; MYO7A, n=2; CDH3, n=1; EYS, n=1), X-linked (XL, n=4: PRPS1, n=1; RPGR, n=3), and autosomal dominant (AD, n=16: IMPDH1, n=3; RP1, n=3; RHO, n=10), with a mean age of disease onset of 38.5, 30.5, and 39.0 years old, respectively. Five of these genes have not previously been reported to cause sector RP (PRPS1, MYO7A, EYS, IMPDH1, and RP1). Inferior and nasal predilection was common across the different genotypes, and patients tended to maintain good central vision. Progression on serial FAF was observed in RPGR, MYO7A, CDH23, EYS, IMPDH1, RP1, and RHO-associated sector RP. CONCLUSIONS: The genotypic spectrum of the disease is broader than previously reported. The longitudinal data provided will help to make accurate patient prognoses and counseling as well as inform patients' potential participation in the increasing numbers of trials of novel therapeutics and access to future treatments.
Authors: Maria L Napier; Dash Durga; Clive J Wolsley; Sarah Chamney; Sharon Alexander; Rosie Brennan; David A Simpson; Giuliana Silvestri; Colin E Willoughby Journal: Ophthalmic Genet Date: 2015 Impact factor: 1.803
Authors: Anika Nanda; Michelle E McClements; Penny Clouston; Morag E Shanks; Robert E MacLaren Journal: Am J Ophthalmol Date: 2019-02-04 Impact factor: 5.258
Authors: Sara J Bowne; Lori S Sullivan; Sarah E Mortimer; Lizbeth Hedstrom; Jingya Zhu; Catherine J Spellicy; Anisa I Gire; Dianna Hughbanks-Wheaton; David G Birch; Richard A Lewis; John R Heckenlively; Stephen P Daiger Journal: Invest Ophthalmol Vis Sci Date: 2006-01 Impact factor: 4.799
Authors: M L Naash; N S Peachey; Z Y Li; C C Gryczan; Y Goto; J Blanks; A H Milam; H Ripps Journal: Invest Ophthalmol Vis Sci Date: 1996-04 Impact factor: 4.799
Authors: Alessia Fiorentino; Kaoru Fujinami; Gavin Arno; Anthony G Robson; Nikolas Pontikos; Monica Arasanz Armengol; Vincent Plagnol; Takaaki Hayashi; Takeshi Iwata; Matthew Parker; Tom Fowler; Augusto Rendon; Jessica C Gardner; Robert H Henderson; Michael E Cheetham; Andrew R Webster; Michel Michaelides; Alison J Hardcastle Journal: Hum Mutat Date: 2017-10-17 Impact factor: 4.878
Authors: Aileen Aherne; Avril Kennan; Paul F Kenna; Niamh McNally; David G Lloyd; Ian L Alberts; Anna-Sophia Kiang; Marian M Humphries; Carmen Ayuso; Paul C Engel; Jing Jin Gu; Beverly S Mitchell; G Jane Farrar; Pete Humphries Journal: Hum Mol Genet Date: 2004-03-15 Impact factor: 6.150
Authors: Nikolas Pontikos; Gavin Arno; Neringa Jurkute; Elena Schiff; Rola Ba-Abbad; Samantha Malka; Ainoa Gimenez; Michalis Georgiou; Genevieve Wright; Monica Armengol; Hannah Knight; Menachem Katz; Mariya Moosajee; Patrick Yu-Wai-Man; Anthony T Moore; Michel Michaelides; Andrew R Webster; Omar A Mahroo Journal: Ophthalmology Date: 2020-04-16 Impact factor: 12.079
Authors: Xuan-Thanh-An Nguyen; Mays Talib; Mary J van Schooneveld; Joost Brinks; Jacoline Ten Brink; Ralph J Florijn; Jan Wijnholds; Robert M Verdijk; Arthur A Bergen; Camiel J F Boon Journal: Int J Mol Sci Date: 2020-01-28 Impact factor: 5.923
Authors: Nina Kobal; Tjaša Krašovec; Maja Šuštar; Marija Volk; Borut Peterlin; Marko Hawlina; Ana Fakin Journal: Int J Mol Sci Date: 2021-02-21 Impact factor: 5.923
Authors: Brian G Ballios; Emily M Place; Luis Martinez-Velazquez; Eric A Pierce; Jason I Comander; Rachel M Huckfeldt Journal: Genes (Basel) Date: 2021-11-23 Impact factor: 4.141
Authors: Evgenia Anikina; Michalis Georgiou; James Tee; Andrew R Webster; Richard G Weleber; Michel Michaelides Journal: Am J Ophthalmol Date: 2021-07-22 Impact factor: 5.258